Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,799 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Rationale, design, and baseline data of the Japanese Primary Prevention Project (JPPP)-a randomized, open-label, controlled trial of aspirin versus no aspirin in patients with multiple risk factors for vascular events.
Teramoto T, Shimada K, Uchiyama S, Sugawara M, Goto Y, Yamada N, Oikawa S, Ando K, Ishizuka N, Yamazaki T, Yokoyama K, Murata M, Ikeda Y. Teramoto T, et al. Among authors: ando k. Am Heart J. 2010 Mar;159(3):361-369.e4. doi: 10.1016/j.ahj.2009.11.030. Am Heart J. 2010. PMID: 20211296 Clinical Trial.
The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009).
Ogihara T, Kikuchi K, Matsuoka H, Fujita T, Higaki J, Horiuchi M, Imai Y, Imaizumi T, Ito S, Iwao H, Kario K, Kawano Y, Kim-Mitsuyama S, Kimura G, Matsubara H, Matsuura H, Naruse M, Saito I, Shimada K, Shimamoto K, Suzuki H, Takishita S, Tanahashi N, Tsuchihashi T, Uchiyama M, Ueda S, Ueshima H, Umemura S, Ishimitsu T, Rakugi H; Japanese Society of Hypertension Committee. Ogihara T, et al. Hypertens Res. 2009 Jan;32(1):3-107. Hypertens Res. 2009. PMID: 19300436 No abstract available.
Effects of daily aspirin on cancer incidence and mortality in the elderly Japanese.
Yokoyama K, Ishizuka N, Uemura N, Mizokami Y, Hiraishi H, Murata M, Uchiyama S, Teramoto T, Shimada K, Yamazaki T, Oikawa S, Sugawara M, Ando K, Ikeda Y; JPPP study group. Yokoyama K, et al. Among authors: ando k. Res Pract Thromb Haemost. 2018 Apr 15;2(2):274-281. doi: 10.1002/rth2.12097. eCollection 2018 Apr. Res Pract Thromb Haemost. 2018. PMID: 30046729 Free PMC article.
Low-Dose Aspirin for Primary Prevention of Cardiovascular Events in Elderly Japanese Patients with Atherosclerotic Risk Factors: Subanalysis of a Randomized Clinical Trial (JPPP-70).
Sugawara M, Goto Y, Yamazaki T, Teramoto T, Oikawa S, Shimada K, Uchiyama S, Ando K, Ishizuka N, Murata M, Yokoyama K, Uemura Y, Ikeda Y; Japanese Primary Prevention Project (JPPP) Study Group. Sugawara M, et al. Among authors: ando k. Am J Cardiovasc Drugs. 2019 Jun;19(3):299-311. doi: 10.1007/s40256-018-0313-0. Am J Cardiovasc Drugs. 2019. PMID: 30565155 Clinical Trial.
Rationale and design of the Eplerenone combination Versus conventional Agents to Lower blood pressure on Urinary Antialbuminuric Treatment Effect (EVALUATE) trial: a double-blinded randomized placebo-controlled trial to evaluate the antialbuminuric effects of an aldosterone blocker in hypertensive patients with albuminuria.
Ando K, Ohtsu H, Arakawa Y, Kubota K, Yamaguchi T, Nagase M, Yamada A, Fujita T; Eplerenone combination Versus conventional Agents to Lower blood pressure on Urinary Antialbuminuric Treatment Effect Study Investigators. Ando K, et al. Hypertens Res. 2010 Jun;33(6):616-21. doi: 10.1038/hr.2010.46. Epub 2010 Apr 9. Hypertens Res. 2010. PMID: 20379190 Clinical Trial.
[Oxidative stress].
Ando K. Ando K. Nihon Rinsho. 2003 Jul;61(7):1130-7. Nihon Rinsho. 2003. PMID: 12877074 Review. Japanese.
3,799 results